Hyperglycemia and cardiovascular disease in patients with type 2 diabetes

Current Opinion in Endocrinology and Diabetes

Volumn 7, Issue 4, 2000, Pages 197-202

  Laakso, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0033912019     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200008000-00004     Document Type: Review

References (37)

1. 1 Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987, 3:463-524.
2. 2 Laakso M, Lehto S: Epidemiology of macrovascular disease in diabetes. Diabetes Rew 1997, 5:294-315.
3. 3 Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA 1999, 281:1291-1297. This paper indicates that the decline in heart disease mortality is much smaller among diabetic subjects than in the general US population.
4. 4 Leibson CL, O'Brien PC, Atkinson E, et al.: Relative contributions of incidence and survival to increasing prevalence of adult-onset diabetes mellitus. Am J Epidemiol 1997, 146:12-22.
5. 5 Sievers ML, Nelson RG, Bennett PH: Sequential trends in overall and cause-specific mortality in diabetic and non-diabetic Pima Indians. Diabetes Care 1996, 19:107-111.
6. 6 Haffner SM, Lehto S, Rönnemaa T, et al.: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234.
7. 7 International Collaborative Group: Asymptomatic hyperglycemia and coronary heart disease: a series of papers by the International Collaborative Group based on studies in fifteen populations. J Chronic Dis 1979, 32:829-837.
8. 8 Coutinho M, Gerstein HC, Wang Y, Yusuf S: The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999, 22:233-240. This meta-analysis convincingly shows that a slight elevation of glucose in the non-diabetic range is associated with cardiovascular disease.
9. 9 Laakso M: Insulin resistance and coronary heart disease. Curr Opin Lipidol 1996, 7:217-226.
10. 10 Lempiäinen P, Mykkänen L, Pyörälä K, et al.: Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999, 100:123-128. The first study, based on factor analysis, to indicate that insulin resistance syndrome predicts coronary heart disease in nondiabetic subjects.
11. 11 Lento S, Rönnemaa T, Pyörälä K, Laakso M: Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia 2000, 43:148-155. The first study, based on factor analysis, to show that insulin resistance syndrome predicts coronary heart disease in patients with type 2 diabetes. In this study, fasting hyperinsulinemia did not predict coronary heart disease independently of confounding factors.
12. 12 Laakso M: Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999, 48:937-942.
13. 13 Uusitupa MIJ, Niskanen LK, Voutilainen E, Pyörälä K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993, 36:1175-1184.
14. 14 Hanefeld M, Fischer S, Julius U, et al., the DIS Group: Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study: 11-year follow-up. Diabetologia 1996, 39:1577-1583.
15. 15 Turner RC, Millns H, Neil HAW, et al. for the United Kingdom Prospective Diabetes Study Group: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). Br Med J 1998, 316:823-828.
16. 16 Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994, 43:960-967.
17. 17 Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 1994, 25:1157-1164.
18. 18 Lento S, Rönnemaa T, Pyörälä K, Laakso M: Predictors of stroke in middle-aged patients with non-insulin dependent diabetes. Stroke 1996, 27:63-68.
19. 19 Lehto S, Rönnemaa T, Haffner SM, et al.: Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997, 48:1354-1359.
20. 20 Andersson DKG, Svärdsudd K: Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 1995, 18:1534-1543.
21. 21 Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995, 18:258-268.
22. 22 Wei M, Gaskill SP, Haffner SM, Stern MP: Effect of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 1998, 21:1167-1172.
23. 23 Gall M-A, Borch-Johnsen K, Hougaard P, et al.: Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995, 44:1303-1309.
24. 24 Standl E, Balletshofer B, Dahl B, et al.: Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Parctioner Project. Diabetologia 1996, 39:1540-1545.
25. 25 Muggeo M, Verlato G, Bonora E, et al.: Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus. The Verona Diabetes Study. Circulation 1997, 96:1750-1754.
26. 26 Bruno G, Merletti F, Boffetta P, et al.: Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus. Diabetologia 1999, 42:297-301.
27. 27 Sievers ML, Bennett PH, Nelson RG: Effect of glycemia on mortality in Pima Indians with type 2 diabetes. Diabetes 1999, 48:896-902.
28. 28 Groeneveld Y, Petri H, Hermans J, Springer MP: Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review. Diabet Med 1999, 16:2-13. A meta-analysis of 27 studies on the relationship between glycemic control and mortality.
29. 29 Temelkova-Kurktschiev T, Koehler C, Leonhardt W, et al.: Increased intimal-medial thickness in newly detected type 2 diabetes. Risk factors. Diabetes Care 1999, 22:333-338.
30. 30 Wagenknect LE, D'Agostino R Jr, Savage PJ, et al.: Duration of diabetes and carotid wall thickness: the Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997, 28:999-1005.
31. 31 Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group: Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Diabetes 1999, 48:383-390.
32. 32 Knatterud GL, Klimt CR, Levin ME, et al.: Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VI. Mortality and selected nonfatal events with insulin treatment. JAMA 1978, 240:37-42.
33. 33 UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853.
34. 34 Laakso M: Benefits of strict glucose and blood pressure control in type 2 diabetes: lessons from the UK Prospective Diabetes Study. Circulation 1999, 99:461-462.
35. 35 Malmberg K: Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Br Med J 1997, 314:1512-1515.
36. 36 Malmberg K, Norhammar A, Wedel H, Ryden L: Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999, 99:2626-2632.
37. 37 King GL, Wakasaki H: Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes. Diabetes Care 1999, (Suppl 3):C31-37. This article presents the current state of knowledge on mechanisms by which poor glycemic control and insulin resistance could cause cardiovascular disease in patients with diabetes.